30.06.2015 • News

Private Equity Said to Eye North Africa Health Market

Private equity groups are increasingly eyeing opportunities in North Africa’s healthcare market, attracted by expanding populations spending more out of their own pockets on private medical services in countries where state provision is inadequate or underfunded, says the UK business newspaper Financial Times (FT).
UAE-based Abraaj, which has $9 billion of assets under management, according to the newspaper, has teamed up this year with three development institutions to establish a $200 million healthcare investment platform, the North Africa Hospital Holdings Group, focused on Egypt and Tunisia.
Abraaj, which already has stakes in hospitals in the two countries, is the biggest contributor to the fund with $145 million. The group’s three partners in the fund are the European Bank for Reconstruction and Development, Germany’s DEG and France’s Proparco.
Across North Africa, government-provided healthcare is falling behind demand, according to research cited by Abraaj. Out-of-pocket expenses by the region’s citizens on medical services averaged 41% of healthcare spending. In Egypt, it is 63%, a regional bank’s report said.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.